The Biology and Pathology of Innate Immunity Mechanisms:
In recent years increased scientific attention has been given to immediate defense mechanisms based on non-clonal recognition of microbial components. These mechanisms constitute the innate immunity arm of the body s defense. Identification of pathogens by these mechanisms involves primarily recepto...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
2002
|
| Schriftenreihe: | Advances in Experimental Medicine and Biology
479 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | In recent years increased scientific attention has been given to immediate defense mechanisms based on non-clonal recognition of microbial components. These mechanisms constitute the innate immunity arm of the body s defense. Identification of pathogens by these mechanisms involves primarily receptors recognizing sugar moieties of various microorganisms. Innate immunity based mechanisms are essential for the existence of multicellular organisms. They are evolutionarily conserved and designed to provide immediate protection against microbial pathogens to eradicate infection. Activation of innate immunity is crucial for transition to specific immunity and for its orientation, and to assist the specific immune response in the recognition of pathogens and their destruction. Innate immunity is regularly involved in the arrest of bacterial, mycotic, viral and parasitic infections, giving the specific immune response time to become effective. It becomes critically essential in immunocompromised patients who fail to mount specific immune responses due to congenital or acquired immunodeficiencies as a result of chemotherapy, dialysis, immunosuppressive drugs, or HIV infection. The Innate Immunity arsenal constitutes polymorphonuclear and mononuclear phagocytes, mast cells, the complement system, Natural Killer cells, antimicrobial peptides, and presumably a subset of T lymphocytes with TCRl receptors |
| Beschreibung: | 1 Online-Ressource (XII, 330 p) |
| ISBN: | 9780306468315 |
| DOI: | 10.1007/b112037 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046149218 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190906s2002 |||| o||u| ||||||eng d | ||
| 020 | |a 9780306468315 |9 978-0-306-46831-5 | ||
| 024 | 7 | |a 10.1007/b112037 |2 doi | |
| 035 | |a (ZDB-2-SBL)978-0-306-46831-5 | ||
| 035 | |a (OCoLC)1119033712 | ||
| 035 | |a (DE-599)BVBBV046149218 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.079 |2 23 | |
| 245 | 1 | 0 | |a The Biology and Pathology of Innate Immunity Mechanisms |c edited by Yona Keisari, Itzhak Ofek |
| 264 | 1 | |a Boston, MA |b Springer US |c 2002 | |
| 300 | |a 1 Online-Ressource (XII, 330 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in Experimental Medicine and Biology |v 479 | |
| 520 | |a In recent years increased scientific attention has been given to immediate defense mechanisms based on non-clonal recognition of microbial components. These mechanisms constitute the innate immunity arm of the body s defense. Identification of pathogens by these mechanisms involves primarily receptors recognizing sugar moieties of various microorganisms. Innate immunity based mechanisms are essential for the existence of multicellular organisms. They are evolutionarily conserved and designed to provide immediate protection against microbial pathogens to eradicate infection. Activation of innate immunity is crucial for transition to specific immunity and for its orientation, and to assist the specific immune response in the recognition of pathogens and their destruction. Innate immunity is regularly involved in the arrest of bacterial, mycotic, viral and parasitic infections, giving the specific immune response time to become effective. It becomes critically essential in immunocompromised patients who fail to mount specific immune responses due to congenital or acquired immunodeficiencies as a result of chemotherapy, dialysis, immunosuppressive drugs, or HIV infection. The Innate Immunity arsenal constitutes polymorphonuclear and mononuclear phagocytes, mast cells, the complement system, Natural Killer cells, antimicrobial peptides, and presumably a subset of T lymphocytes with TCRl receptors | ||
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Infectious Diseases | |
| 650 | 4 | |a Medical Microbiology | |
| 650 | 4 | |a Virology | |
| 650 | 4 | |a Parasitology | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Emerging infectious diseases | |
| 650 | 4 | |a Microbiology | |
| 650 | 4 | |a Medical virology | |
| 650 | 4 | |a Medical parasitology | |
| 650 | 0 | 7 | |a Humorale Immunität |0 (DE-588)4160794-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 655 | 7 | |8 2\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1999 |z Beer Sheva |2 gnd-content | |
| 689 | 0 | 0 | |a Humorale Immunität |0 (DE-588)4160794-6 |D s |
| 689 | 0 | |8 3\p |5 DE-604 | |
| 700 | 1 | |a Keisari, Yona |4 edt | |
| 700 | 1 | |a Ofek, Itzhak |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475786477 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306464096 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781475786460 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/b112037 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 940 | 1 | |q ZDB-2-SBL_2000/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031529395 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/b112037 |l UBR01 |p ZDB-2-SBL |q ZDB-2-SBL_2000/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180490494672896 |
|---|---|
| any_adam_object | |
| author2 | Keisari, Yona Ofek, Itzhak |
| author2_role | edt edt |
| author2_variant | y k yk i o io |
| author_facet | Keisari, Yona Ofek, Itzhak |
| building | Verbundindex |
| bvnumber | BV046149218 |
| collection | ZDB-2-SBL |
| ctrlnum | (ZDB-2-SBL)978-0-306-46831-5 (OCoLC)1119033712 (DE-599)BVBBV046149218 |
| dewey-full | 616.079 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.079 |
| dewey-search | 616.079 |
| dewey-sort | 3616.079 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/b112037 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03763nmm a2200625zcb4500</leader><controlfield tag="001">BV046149218</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190906s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780306468315</subfield><subfield code="9">978-0-306-46831-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/b112037</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)978-0-306-46831-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119033712</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046149218</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.079</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The Biology and Pathology of Innate Immunity Mechanisms</subfield><subfield code="c">edited by Yona Keisari, Itzhak Ofek</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XII, 330 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in Experimental Medicine and Biology</subfield><subfield code="v">479</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In recent years increased scientific attention has been given to immediate defense mechanisms based on non-clonal recognition of microbial components. These mechanisms constitute the innate immunity arm of the body s defense. Identification of pathogens by these mechanisms involves primarily receptors recognizing sugar moieties of various microorganisms. Innate immunity based mechanisms are essential for the existence of multicellular organisms. They are evolutionarily conserved and designed to provide immediate protection against microbial pathogens to eradicate infection. Activation of innate immunity is crucial for transition to specific immunity and for its orientation, and to assist the specific immune response in the recognition of pathogens and their destruction. Innate immunity is regularly involved in the arrest of bacterial, mycotic, viral and parasitic infections, giving the specific immune response time to become effective. It becomes critically essential in immunocompromised patients who fail to mount specific immune responses due to congenital or acquired immunodeficiencies as a result of chemotherapy, dialysis, immunosuppressive drugs, or HIV infection. The Innate Immunity arsenal constitutes polymorphonuclear and mononuclear phagocytes, mast cells, the complement system, Natural Killer cells, antimicrobial peptides, and presumably a subset of T lymphocytes with TCRl receptors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical Microbiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Parasitology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Emerging infectious diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Microbiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical parasitology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Humorale Immunität</subfield><subfield code="0">(DE-588)4160794-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1999</subfield><subfield code="z">Beer Sheva</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Humorale Immunität</subfield><subfield code="0">(DE-588)4160794-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Keisari, Yona</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ofek, Itzhak</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475786477</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306464096</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781475786460</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/b112037</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031529395</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/b112037</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">ZDB-2-SBL_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift gnd-content 2\p (DE-588)1071861417 Konferenzschrift 1999 Beer Sheva gnd-content |
| genre_facet | Konferenzschrift Konferenzschrift 1999 Beer Sheva |
| id | DE-604.BV046149218 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:35Z |
| institution | BVB |
| isbn | 9780306468315 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031529395 |
| oclc_num | 1119033712 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XII, 330 p) |
| psigel | ZDB-2-SBL ZDB-2-SBL_2000/2004 ZDB-2-SBL ZDB-2-SBL_2000/2004 |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Springer US |
| record_format | marc |
| series2 | Advances in Experimental Medicine and Biology |
| spelling | The Biology and Pathology of Innate Immunity Mechanisms edited by Yona Keisari, Itzhak Ofek Boston, MA Springer US 2002 1 Online-Ressource (XII, 330 p) txt rdacontent c rdamedia cr rdacarrier Advances in Experimental Medicine and Biology 479 In recent years increased scientific attention has been given to immediate defense mechanisms based on non-clonal recognition of microbial components. These mechanisms constitute the innate immunity arm of the body s defense. Identification of pathogens by these mechanisms involves primarily receptors recognizing sugar moieties of various microorganisms. Innate immunity based mechanisms are essential for the existence of multicellular organisms. They are evolutionarily conserved and designed to provide immediate protection against microbial pathogens to eradicate infection. Activation of innate immunity is crucial for transition to specific immunity and for its orientation, and to assist the specific immune response in the recognition of pathogens and their destruction. Innate immunity is regularly involved in the arrest of bacterial, mycotic, viral and parasitic infections, giving the specific immune response time to become effective. It becomes critically essential in immunocompromised patients who fail to mount specific immune responses due to congenital or acquired immunodeficiencies as a result of chemotherapy, dialysis, immunosuppressive drugs, or HIV infection. The Innate Immunity arsenal constitutes polymorphonuclear and mononuclear phagocytes, mast cells, the complement system, Natural Killer cells, antimicrobial peptides, and presumably a subset of T lymphocytes with TCRl receptors Immunology Infectious Diseases Medical Microbiology Virology Parasitology Emerging infectious diseases Microbiology Medical virology Medical parasitology Humorale Immunität (DE-588)4160794-6 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift gnd-content 2\p (DE-588)1071861417 Konferenzschrift 1999 Beer Sheva gnd-content Humorale Immunität (DE-588)4160794-6 s 3\p DE-604 Keisari, Yona edt Ofek, Itzhak edt Erscheint auch als Druck-Ausgabe 9781475786477 Erscheint auch als Druck-Ausgabe 9780306464096 Erscheint auch als Druck-Ausgabe 9781475786460 https://doi.org/10.1007/b112037 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | The Biology and Pathology of Innate Immunity Mechanisms Immunology Infectious Diseases Medical Microbiology Virology Parasitology Emerging infectious diseases Microbiology Medical virology Medical parasitology Humorale Immunität (DE-588)4160794-6 gnd |
| subject_GND | (DE-588)4160794-6 (DE-588)1071861417 |
| title | The Biology and Pathology of Innate Immunity Mechanisms |
| title_auth | The Biology and Pathology of Innate Immunity Mechanisms |
| title_exact_search | The Biology and Pathology of Innate Immunity Mechanisms |
| title_full | The Biology and Pathology of Innate Immunity Mechanisms edited by Yona Keisari, Itzhak Ofek |
| title_fullStr | The Biology and Pathology of Innate Immunity Mechanisms edited by Yona Keisari, Itzhak Ofek |
| title_full_unstemmed | The Biology and Pathology of Innate Immunity Mechanisms edited by Yona Keisari, Itzhak Ofek |
| title_short | The Biology and Pathology of Innate Immunity Mechanisms |
| title_sort | the biology and pathology of innate immunity mechanisms |
| topic | Immunology Infectious Diseases Medical Microbiology Virology Parasitology Emerging infectious diseases Microbiology Medical virology Medical parasitology Humorale Immunität (DE-588)4160794-6 gnd |
| topic_facet | Immunology Infectious Diseases Medical Microbiology Virology Parasitology Emerging infectious diseases Microbiology Medical virology Medical parasitology Humorale Immunität Konferenzschrift Konferenzschrift 1999 Beer Sheva |
| url | https://doi.org/10.1007/b112037 |
| work_keys_str_mv | AT keisariyona thebiologyandpathologyofinnateimmunitymechanisms AT ofekitzhak thebiologyandpathologyofinnateimmunitymechanisms |